Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.76 USD | +3.71% | +44.48% | +49.64% |
May. 15 | B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating | MT |
May. 14 | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 195.8 | 176.6 | 232.4 | 439.7 | 393.3 | 571.8 | - | - |
Enterprise Value (EV) 1 | 195.8 | 176.6 | 232.4 | 439.7 | 393.3 | 571.8 | 571.8 | 571.8 |
P/E ratio | 778 x | -52.8 x | -12.5 x | -28.9 x | -14.9 x | -30.8 x | 29.8 x | 9.52 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 3.83 x | 3.61 x | 3.21 x | 4.96 x | 3.02 x | 3.15 x | 2.3 x | 1.89 x |
EV / Revenue | 3.83 x | 3.61 x | 3.21 x | 4.96 x | 3.02 x | 3.15 x | 2.3 x | 1.89 x |
EV / EBITDA | 42.7 x | 30.9 x | 11.9 x | 33.8 x | 14 x | 16.1 x | 7.71 x | 4.69 x |
EV / FCF | - | - | 70.5 x | - | - | 381 x | 16.6 x | - |
FCF Yield | - | - | 1.42% | - | - | 0.26% | 6.02% | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 25,173 | 25,746 | 26,903 | 29,790 | 35,118 | 35,382 | - | - |
Reference price 2 | 7.780 | 6.860 | 8.640 | 14.76 | 11.20 | 16.76 | 16.76 | 16.76 |
Announcement Date | 3/13/20 | 3/8/21 | 3/10/22 | 3/23/23 | 3/19/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 51.16 | 48.87 | 72.48 | 88.6 | 130.2 | 181.3 | 248.6 | 303 |
EBITDA 1 | 4.583 | 5.715 | 19.5 | 13.02 | 28.12 | 35.43 | 74.12 | 121.9 |
EBIT 1 | -4.803 | 0.385 | 1.614 | 1.919 | 0.431 | 3.44 | 44.12 | 93.55 |
Operating Margin | -9.39% | 0.79% | 2.23% | 2.17% | 0.33% | 1.9% | 17.74% | 30.88% |
Earnings before Tax (EBT) 1 | -0.125 | -3.415 | -17.87 | -14.01 | -23.71 | -17.84 | 27.62 | 83.12 |
Net income 1 | 0.168 | -3.357 | -18.48 | -14.09 | -24.41 | -19.19 | 21.79 | 78.14 |
Net margin | 0.33% | -6.87% | -25.5% | -15.9% | -18.75% | -10.58% | 8.76% | 25.79% |
EPS 2 | 0.0100 | -0.1300 | -0.6900 | -0.5100 | -0.7500 | -0.5433 | 0.5633 | 1.760 |
Free Cash Flow 1 | - | - | 3.296 | - | - | 1.5 | 34.4 | - |
FCF margin | - | - | 4.55% | - | - | 0.83% | 13.83% | - |
FCF Conversion (EBITDA) | - | - | 16.91% | - | - | 4.23% | 46.41% | - |
FCF Conversion (Net income) | - | - | - | - | - | - | 157.9% | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/13/20 | 3/8/21 | 3/10/22 | 3/23/23 | 3/19/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 20.19 | 22.12 | 23.32 | 22.82 | 20.33 | 26.1 | 33.47 | 34.26 | 36.36 | 34.59 | 42.42 | 49.03 | 56.19 | 53.9 | 61.02 |
EBITDA 1 | 4.599 | 4.94 | 4.505 | -1.021 | 1.089 | 5.342 | 11 | 9.209 | 2.563 | 0.227 | 5.91 | 11.43 | 16.75 | 10.84 | 16.76 |
EBIT 1 | -1.755 | 2.101 | 1.69 | -0.094 | -1.778 | 1.21 | 2.352 | 1.744 | -4.875 | -6.928 | -1.683 | 4.407 | 8.027 | 3.665 | 9.195 |
Operating Margin | -8.69% | 9.5% | 7.25% | -0.41% | -8.75% | 4.64% | 7.03% | 5.09% | -13.41% | -20.03% | -3.97% | 8.99% | 14.28% | 6.8% | 15.07% |
Earnings before Tax (EBT) 1 | -7.285 | -2.438 | -6.199 | -6.429 | 1.055 | -6.931 | -4.244 | -2.852 | -9.683 | -13.56 | -6.973 | -0.8467 | 2.82 | -1.12 | 4.445 |
Net income 1 | -7.418 | -2.438 | -6.239 | -6.464 | 1.055 | -6.643 | -4.229 | -4.391 | -9.148 | -13.56 | -6.51 | -1.243 | 2.117 | -1.285 | 3.025 |
Net margin | -36.74% | -11.02% | -26.75% | -28.32% | 5.19% | -25.45% | -12.64% | -12.81% | -25.16% | -39.22% | -15.35% | -2.54% | 3.77% | -2.38% | 4.96% |
EPS 2 | -0.2700 | -0.0900 | -0.2300 | -0.2400 | 0.0400 | -0.2200 | -0.1400 | -0.1300 | -0.2600 | -0.3800 | -0.2000 | -0.0550 | 0.0875 | -0.0350 | 0.0850 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/10/22 | 5/5/22 | 8/9/22 | 11/14/22 | 3/23/23 | 5/11/23 | 8/9/23 | 11/13/23 | 3/19/24 | 5/13/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | 3.3 | - | - | 1.5 | 34.4 | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | - | 1.79 | 2.6 | - | 0.4 | 0.75 | - |
Capex / Sales | - | - | 2.46% | 2.93% | - | 0.22% | 0.3% | - |
Announcement Date | 3/13/20 | 3/8/21 | 3/10/22 | 3/23/23 | 3/19/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.64% | 572M | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- HROW Stock
- Financials Harrow, Inc.